Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02044601
Title Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

lung non-small cell carcinoma


Carboplatin + Onartuzumab + Paclitaxel

Carboplatin + Erlotinib + Onartuzumab + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.